Pilot Trial of Preoperative (Neoadjuvant) Letrozole in Combination With Bevacizumab in Postmenopausal Women With Newly Diagnosed Estrogen Receptor–or Progesterone Receptor–Positive Breast Cancer

INTRODUCTION: Tumor content or expression of vascular endothelial growth factor (VEGF) is associated with impaired efficacy of antiestrogen adjuvant therapy. We designed a pilot study to assess the feasibility and short-term efficacy of neoadjuvant letrozole and bevacizumab (anti-VEGF) in postmenopa...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Clin Breast Cancer
Autores principales: Forero-Torres, Andres, Saleh, Mansoor N., Galleshaw, Janice A., Jones, Cheryl F., Shah, Jatin J., Percent, Ivor J., Nabell, Lisle M., Carpenter, John T., Falkson, Carla I., Krontiras, Helen, Urist, Marshall M., Bland, Kirby I., De Los Santos, Jennifer F., Meredith, Ruby F., Caterinicchia, Valerie, Bernreuter, Wanda K., O'Malley, Janis P., Li, Yufeng, LoBuglio, Albert F.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2010
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4451110/
https://ncbi.nlm.nih.gov/pubmed/20705559
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3816/CBC.2010.n.035
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares